#5 - CVS Health Corp (NYSE:CVS)
CVS Health Corp (NYSE: CVS) - Bargain hunting is a quintessentially American activity, and right now – if the fundamentals are to be believed – CVS is trading at a real bargain to its sector. Unlike other companies with a retail infrastructure, pharmacies have remained somewhat immune from online threats. This differentiation looks to continue with the roll-out of CVS health hubs which will be an in-store pilot program that will help patients manage chronic conditions with limited health services, wellness products, and personalized care. One of the concerns weighing on the minds of investors is debt related to their deal with Aetna, and also the (slim) possibility that the deal would fall through. However, the company has got its balance sheet in good shape. They’ve paid off $4 billion in debt which means they will be showing significantly less leverage on their books by 2022. The company generates significant free cash flow (FCF) that they will also be able to apply towards debt repayment. CVS also had a strong first-quarter earnings report.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Read More - Current Price
- $44.36
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 13 Buy Ratings, 6 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $69.12 (55.8% Upside)
